Scholars Central

Research articlePublished 31 Oct 2013

Chemical equivalence study on four brands of α-methyldopa

Authors: Baba Haruna, Odimba E. Adaku, Cyril O. Usifoh

Journal of Chemical and Pharmaceutical Research

Volume 5 · Issue 10 · Pages 356–358

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Substandard pharmaceutical products have a deleterious effect on health care delivery at all levels. The manufacturers of health products, the medical practitioners and the patients are all affected by substandard medicines but the patient is the worst hit. Methyldopa is an important anti-hypertensive agent used in the management of hypertension. The chemical equivalence of four brands of methyldopa was carried out using the United State Pharmacopoeia (USP) method, which involve non-aqueous titration. Three out of the four brands of methyldopa passed the test that is the percentage content fell within the specified range of 90-110% while one of the samples failed the test with percentage content of 82.07%. This finding points to the need for regular quality checks on pharmaceutical products in circulation.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Chemical and Pharmaceutical Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Chemical and Pharmaceutical Research
  • SubjectPharmaceutical Sciences
  • SubjectChemistry
  • BylineArticles whose byline prints “Baba Haruna”
  • BylineArticles whose byline prints “Odimba E. Adaku”
  • BylineArticles whose byline prints “Cyril O. Usifoh”